Literature DB >> 1624295

Gene amplification and overexpression of epidermal growth factor receptor in squamous cell carcinoma of the head and neck.

K Rikimaru1, K Tadokoro, T Yamamoto, S Enomoto, N Tsuchida.   

Abstract

The degree of gene amplification for epidermal growth factor receptor (EGFR) and its expression levels were examined in 4 cases of tumor lesions and their cell lines of human squamous cell carcinoma (SCC) of the oral cavity. The amplification was detected in 1 case (ZA), but not significantly in 3 other cases (HOC605, HOC815, and HOC927) in which the amplification did not occur during the cell line establishment. In those 3 cases, levels of EGFR synthesis and human EGF (hEGF) binding capacity were varied: HOC605 and HOC815 had slightly increased levels of hEGF binding capacity and EGFR synthesis, respectively. While HOC927 had the lowest levels of both, the hEGF binding capacity was elevated in the tumor lesion when compared with the normal counterpart of the same patient. These results suggest that the increased capacity for EGF binding plays a more important role than does gene amplification on the tumorigenesis of SCC of the head and neck.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1624295     DOI: 10.1002/hed.2880140103

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  10 in total

Review 1.  Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma.

Authors:  Giovana R Thomas; Hari Nadiminti; Jacinto Regalado
Journal:  Int J Exp Pathol       Date:  2005-12       Impact factor: 1.925

2.  Minimally invasive colorectal resection is associated with a rapid and sustained decrease in plasma levels of epidermal growth factor (EGF) in the colon cancer setting.

Authors:  Michael J Grieco; H M C Shantha Kumara; Raymond Baxter; Nadav Dujovny; Matthew F Kalady; Vesna Cekic; Martin Luchtefeld; Richard L Whelan
Journal:  Surg Endosc       Date:  2010-03-31       Impact factor: 4.584

3.  Potential roles of Centipede Scolopendra extracts as a strategy against EGFR-dependent cancers.

Authors:  Weina Ma; Dongdong Zhang; Lei Zheng; Yingzhuan Zhan; Yanmin Zhang
Journal:  Am J Transl Res       Date:  2015-01-15       Impact factor: 4.060

Review 4.  Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck.

Authors:  P G Sacks
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

5.  Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas.

Authors:  Hatem O Kaseb; Helene Fohrer-Ting; Dale W Lewis; Eric Lagasse; Susanne M Gollin
Journal:  Exp Cell Res       Date:  2016-09-09       Impact factor: 3.905

Review 6.  Epidermal growth factor receptor inhibition in cancer therapy: biology, rationale and preliminary clinical results.

Authors:  S M Huang; P M Harari
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.651

7.  Recurrent CDK1 overexpression in laryngeal squamous cell carcinoma.

Authors:  K Bednarek; K Kiwerska; M Szaumkessel; M Bodnar; M Kostrzewska-Poczekaj; A Marszalek; J Janiszewska; A Bartochowska; J Jackowska; M Wierzbicka; R Grenman; K Szyfter; M Giefing; M Jarmuz-Szymczak
Journal:  Tumour Biol       Date:  2016-02-24

8.  Comparison of DNA copy numbers in original oral squamous cell carcinomas and corresponding cell lines by comparative genomic hybridization.

Authors:  T Komiyama; K Matsumura; N Tsuchida
Journal:  Jpn J Cancer Res       Date:  1997-05

Review 9.  Analysis of Progress and Challenges of EGFR-Targeted Molecular Imaging in Cancer With a Focus on Affibody Molecules.

Authors:  Weizhi Chen; Baozhong Shen; Xilin Sun
Journal:  Mol Imaging       Date:  2019 Jan-Dec       Impact factor: 4.488

10.  Expression of epithelial growth factor receptor in oral epithelial dysplastic lesions.

Authors:  Manickam Rajakili Chockalingam Rajeswari; Thillai Rajasekaran Saraswathi
Journal:  J Oral Maxillofac Pathol       Date:  2012-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.